Feedback / Questions
KLN-1010 - Kelonia Therap
https://www.businesswire.com/news/home/20250819154555/en/Kelonia-Therapeutics-Doses-First-Patient-in-Phase-1-inMMyCAR-Study-Evaluating-in-vivo-CAR-T-Cell-Therapy-for-Relapsed-and-Refractory-Multiple-Myeloma
Aug 19, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next